I have to ask, if you read the links I posted, why are you still confusing this law with the tagging of three drugs?
I will put it simply for you. The tagging of three medications, specifically Viagra, OxyContin, and another by GlaxoSmithKline, is a measure taken largely by the manufacturers of each drug. This is a separate initiative that has nothing to do with Radio Frequency Identification tags on drugs.
What this bill does is state that in order to get money for a controlled substance monitoring program, states must set up a database of all drugs in Schedules II, III, and IV, including the following information:
(A) Drug Enforcement Administration Registration Number of the dispenser. (B) Drug Enforcement Administration Registration Number and name of the practitioner who prescribed the drug. (C) Name, address, and telephone number of the ultimate user or research subject. (D) Identification of the drug by a national drug code number. (E) Quantity dispensed. (F) Estimated number of days for which such quantity should last. (G) Number of refills ordered. (H) Whether the drug was dispensed as a refill of a prescription or as a first-time request. (I) Date of the dispensing. (J) Date of origin of the prescription.
The information in the state's database must be shared, upon request, with
(2) any local, State, or Federal law enforcement, narcotics control, licensure, disciplinary, or program authority, who certifies, under the procedures determined by the State, that the requested information is related to an individual investigation or proceeding involving the unlawful diversion or misuse of a schedule II, III, or IV substance, and such information will further the purpose of the investigation or assist in the proceeding;
(3) any agent of the Department of Health and Human Services, a State medicaid program, a State health department, or the Drug Enforcement Administration who certifies that the requested information is necessary for research to be conducted by such department, program, or administration, respectively, and the intended purpose of the research is related to a function committed to such department, program, or administration by law that is not investigative in nature; or
(4) any agent of another State, who certifies that the State has an application approved under this section and the requested information is for the purpose of implementing the State's controlled substance monitoring program under this section.
no subject
I will put it simply for you. The tagging of three medications, specifically Viagra, OxyContin, and another by GlaxoSmithKline, is a measure taken largely by the manufacturers of each drug. This is a separate initiative that has nothing to do with Radio Frequency Identification tags on drugs.
What this bill does is state that in order to get money for a controlled substance monitoring program, states must set up a database of all drugs in Schedules II, III, and IV, including the following information:
(A) Drug Enforcement Administration Registration Number of the dispenser.
(B) Drug Enforcement Administration Registration Number and name of the practitioner who prescribed the drug.
(C) Name, address, and telephone number of the ultimate user or research subject.
(D) Identification of the drug by a national drug code number.
(E) Quantity dispensed.
(F) Estimated number of days for which such quantity should last.
(G) Number of refills ordered.
(H) Whether the drug was dispensed as a refill of a prescription or as a first-time request.
(I) Date of the dispensing.
(J) Date of origin of the prescription.
The information in the state's database must be shared, upon request, with
(2) any local, State, or Federal law enforcement, narcotics control, licensure, disciplinary, or program authority, who certifies, under the procedures determined by the State, that the requested information is related to an individual investigation or proceeding involving the unlawful diversion or misuse of a schedule II, III, or IV substance, and such information will further the purpose of the investigation or assist in the proceeding;
(3) any agent of the Department of Health and Human Services, a State medicaid program, a State health department, or the Drug Enforcement Administration who certifies that the requested information is necessary for research to be conducted by such department, program, or administration, respectively, and the intended purpose of the research is related to a function committed to such department, program, or administration by law that is not investigative in nature; or
(4) any agent of another State, who certifies that the State has an application approved under this section and the requested information is for the purpose of implementing the State's controlled substance monitoring program under this section.